At the Children’s Cancer Research Fund, we know only too well the devastating impact of a childhood cancer diagnosis. Our charity began following the loss of five-year-old Rosie, who died as a result of neuroblastoma. Rosie’s parents, Lisa and Patrick set up the charity with the aim that, in the future, no other parent will be told there is nothing that can be done to save their child.
With a gift in your will to the Children’s Cancer Research Fund, you will be instrumental in advancing promising scientific progress – giving children with cancer not just the chance to survive, but the opportunity to thrive and live full, healthy lives.
Thank you for considering leaving us a gift in your Will. Any gift, whether large or small, will make a difference to many young lives.
For more information about writing or updating your Will, please visit Remember A Charity’s guide on making a Will
We are delighted to offer our supporters in England and Wales an offer of up to 20% off the cost of their Will. You can start your Will online or via telephone and access legal advice from Co-op’s specialist advisory team. Further details, including the discount code, can be found here: https://www.co-oplegalservices.co.uk/partners/remember-a-charity-referrals/
If you are ready to complete or update your Will, here are our details:
There are three main ways to name a charity in your Will. These are:
It is important to review your will throughout your lifetime, particularly after changes such as marriage, divorce or welcoming children or grandchildren.
© 2025 Children’s Cancer Research Fund | Charity No. 1046278 | Website by ATTAIN.
Lorna is Senior Research Fellow & Patient Engagement Lead at the CCLG TYA Research Centre. She is also a Director at the University College London Hospitals NHS Foundation Trust.
Lorna is an internationally recognised leader in teenage and young adult oncology, with 20 years’ research experience across academic, industry, clinical and healthcare settings. She has led a diverse research and development portfolio. Her expertise includes early diagnosis and detection, research and innovation, inequalities in access to care and research, and patient engagement. A member of the Department of Health and Social Care Children’s and Young Persons Advisory Task Force, Lorna chairs national multi-stakeholder and patient initiatives and is an invited keynote speaker, media contributor and parliamentary presenter.
Nancy, 11, was diagnosed with rhabdomyosarcoma when she was just 2 years old. She was treated with Proton Beam Therapy (PBT) in Germany but unfortunately relapsed less than a year later. The family were then sent to Germany for a second round of PBT. Although treatment helped to cure Nancy’s cancer, she has been left with lots of lasting effects which will require ongoing treatment throughout her life. Here Nancy and her mum, Antonia, share their story in the hope it will help others, raise awareness, and raise more money for children’s cancer research.
Why I am a Trustee of CCRF
I have spent my professional career representing individuals and families affected by the devastating asbestos-related cancer, mesothelioma, which has no cure and for which there are only a limited number of palliative treatments available on the NHS.
I joined CCRF because I wanted to bring my understanding of the need to raise awareness of less well known cancers and passion for the need to secure improved funding for research to children facing a cancer diagnosis.
My role on the Board
I am responsible for oversight of our collaboration agreements with other charities to co-fund research into cures and treatments for childhood cancers. I also manage our challenge events and help with community fundraising.
My Background
I am a Senior Associate at Irwin Mitchell LLP and specialise in Asbestos Disease Litigation, acting on behalf of victims of asbestos related diseases and their families. Over the years, I have undertaken a number of fundraising challenges to raise money for cancer research, including a 1000 mile cycle ride from Glasgow to Southampton.